Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration.

Topal, Tuncay; Kar, Taner; Yildirim, Yildiray; Sagdiç, Sercan Koray; Büyükavsar, Cihan; Kaya, Abdullah; Ayata, Ali; Sönmez, Murat; Ünal, Melih Hamdi

Topal, Tuncay; Kar, Taner; Yildirim, Yildiray; Sagdiç, Sercan Koray; Büyükavsar, Cihan; Kaya, Abdullah; Ayata, Ali; Sönmez, Murat; Ünal, Melih Hamdi.

Affiliation

Topal T; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Kar T; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Yildirim Y; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Sagdiç SK; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Büyükavsar C; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Kaya A; Anittepe Military Dispensary, Ankara, Turkey.
Ayata A; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Sönmez M; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.
Ünal MH; Haydarpasa Sultan Abdülhamid Training and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey.

Turk J Ophthalmol ; 47(3): 133-137, 2017 Jun.

Article de En | MEDLINE | ID: mdl-28630787

Mots clés

Aflibercept; central retinal thickness; pigment epithelial detachment; visual acuity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies Langue: En Journal: Turk J Ophthalmol Année: 2017 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google